TY  - GEN
AU  - Kollareddy,Madhu
AU  - Sherrard,Alice
AU  - Park,Ji Hyun
AU  - Szemes,Marianna
AU  - Gallacher,Kelli
AU  - Melegh,Zsombor
AU  - Oltean,Sebastian
AU  - Michaelis,Martin
AU  - Cinatl,Jindrich
AU  - Kaidi,Abderrahmane
AU  - Malik,Karim
TI  - The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis
SN  - 1872-7980
PY  - 2017///0926
KW  - Antimitotic Agents
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Apoptosis
KW  - drug effects
KW  - Aurora Kinase A
KW  - antagonists & inhibitors
KW  - Azepines
KW  - Cell Cycle
KW  - Cell Line, Tumor
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Multiple
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Humans
KW  - Indoles
KW  - Inhibitory Concentration 50
KW  - Kinetochores
KW  - Mitosis
KW  - Neuroblastoma
KW  - drug therapy
KW  - Paclitaxel
KW  - Prometaphase
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - RNA Interference
KW  - Signal Transduction
KW  - Spindle Apparatus
KW  - Time Factors
KW  - Transfection
KW  - Tumor Suppressor Protein p53
KW  - genetics
KW  - Vincristine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2017.05.027
ER  -